Brief: Mink Therapeutics Announces Publication Of Complete Remission
11/07/2025 12:33
July 11 (Reuters) - Mink Therapeutics Inc INKT.O: MINK THERAPEUTICS ANNOUNCES PUBLICATION OF COMPLETE REMISSION FOLLOWING ALLOGENEIC INKT CELL THERAPY IN METASTATIC TESTICULAR CANCER Source text: ID:nGNX20zmcj Further company coverage: INKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's